E-LIB Suche - Ergebnisse für: Blay, J-Y.

1

89P IMmunotherapy response associated clinical and biologic..:

Fazel, M. ; Varnier, R. ; Blay, J-Y..
ESMO Open. 9 (2024) - p. 102478 , 2024

Link: https://doi.org/10.1016/..

2

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open. 9 (2024) - p. 102442 , 2024

Link: https://doi.org/10.1016/..

3

170P Change in the epidemiology and costs of metastatic lun..:

de Pouvourville, G. ; Chouaid, C. ; Marchal, C....
ESMO Open. 9 (2024) - p. 102745 , 2024

Link: https://doi.org/10.1016/..

4

59MO COTESARC – A multicentre, phase I-II clinical trial ev..:

Dufresne, A. ; Brahmi, M. ; Cropet, C....
ESMO Open. 9 (2024) - p. 102449 , 2024

Link: https://doi.org/10.1016/..

5

VP3-2024: A randomized study of 6 vs 3 years of adjuvant im..:

Le Cesne, A. ; Schiffler, C. ; Bouche, O....
Annals of Oncology. 35 (2024) 6 - p. 576-577 , 2024

Link: https://doi.org/10.1016/..

6

62P Updated overall survival and safety with ripretinib vs ..:

Blay, J-Y. ; Jones, R.L. ; Gelderblom, H....
ESMO Open. 9 (2024) - p. 102452 , 2024

Link: https://doi.org/10.1016/..

7

54O Health state impacts of afamitresgene autoleucel (afami..:

Wagner, M. ; Lunt, C. ; Araujo, D....
ESMO Open. 9 (2024) - p. 102444 , 2024

Link: https://doi.org/10.1016/..

8

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade ..:

Blay, JY ; Tlemsani, C. ; Toulmonde, M....
European Journal of Cancer. 196 (2024) - p. 113454 , 2024

Link: https://doi.org/10.1016/..

9

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvan..:

Le Cesne, A. ; Chabaud, S. ; Bouche, O....
ESMO Open. 9 (2024) - p. 102445 , 2024

Link: https://doi.org/10.1016/..

10

66P Therapeutic opportunities in sarcomas and rare tumors: ..:

Vanacker, H. ; Brahmi, M. ; Cassier, P....
ESMO Open. 8 (2023) 1 - p. 101103 , 2023

Link: https://doi.org/10.1016/..

11

157P PCM4EU academy: An educational program for precision o..:

Verlingue, L. ; Antouly, M. ; Witczak, M...
ESMO Open. 8 (2023) 1 - p. 102006 , 2023

Link: https://doi.org/10.1016/..

12

190P EORTC-SPECTA Arcagen project: Results of the prospecti..:

Tagliamento, M. ; Morfouace, M. ; Loizides, C....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S143-S144 , 2023

Link: https://doi.org/10.1016/..

13

64P Tertiary lymphoid structure and efficacy of doxorubicin..:

Grassi, M. ; Dufresne, A. ; Karanian, M....
ESMO Open. 8 (2023) 1 - p. 101101 , 2023

Link: https://doi.org/10.1016/..

14

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nat..:

Blay, JY ; Piperno-Neumann, S. ; Watson, S....
European Journal of Cancer. 192 (2023) - p. 113262 , 2023

Link: https://doi.org/10.1016/..

15

P63 Patient-Reported Outcomes Following Treatment with Vims..:

Blay, JY ; Gelderblom, H ; Rutkowski, P...
Value in Health. 25 (2022) 12 - p. S15 , 2022

Link: https://doi.org/10.1016/..